Geneviève Deceuninck

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

Danuta M. Skowronski, Yossi Febriani, Solmaz Setayeshgar et al. · Clinical Infectious Diseases · 2022 · 135 citations · Full text

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study

Sara Carazo, Danuta M. Skowronski, Marc Brisson et al. · The Lancet Infectious Diseases · 2022 · 121 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +8

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada

Geneviève Deceuninck, Gaston De Serres, Nicole Boulianne et al. · Vaccine · 2015 · 119 citations

Vaccination, Vaccine Safety, Invasive Pneumococcal Disease +7

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines

Caitlin Dodd, Silvana Romio, Steven Black et al. · Vaccine · 2013 · 105 citations · Full text

Vaccination, Vaccine Safety, Cross-protection +11

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec

Jacques Montplaisir, Dominique Petit, Marie-Josée Quinn et al. · PLoS ONE · 2014 · 102 citations · Full text